Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 2, Pages 1624
Publisher
MDPI AG
Online
2023-01-16
DOI
10.3390/ijms24021624
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insights into N6-methyladenosine and programmed cell death in cancer
- (2022) Li Liu et al. Molecular Cancer
- Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis
- (2022) Qiaoling Xiao et al. Frontiers in Oncology
- The dual role of autophagy in acute myeloid leukemia
- (2022) Wonhyoung Seo et al. Journal of Hematology & Oncology
- L3MBTL2-mediated CGA transcriptional suppression promotes pancreatic cancer progression through modulating autophagy
- (2022) Hua Huang et al. iScience
- R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
- (2021) Ying Qing et al. MOLECULAR CELL
- Oxidative stress induces downregulation of TP53INP2 and suppresses osteogenic differentiation of BMSCs during osteoporosis through the autophagy degradation pathway
- (2021) Yuehua Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dysregulation of LINC00470 and METTL3 promotes chemoresistance and suppresses autophagy of chronic myelocytic leukaemia cells
- (2021) Xun Lai et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG
- (2021) Liu-shan Chen et al. ACTA PHARMACOLOGICA SINICA
- NOVEL NPM1 EXON 5 MUTATIONS AND GENE FUSIONS LEADING TO ABERRANT CYTOPLASMIC NUCLEOPHOSMIN IN AML
- (2021) Maria Paola Martelli et al. BLOOD
- miR-142-3p Regulates Tumor Cell Autophagy and Promotes Colon Cancer Progression by Targeting TP53INP2
- (2021) Jiujian Zheng et al. CHEMOTHERAPY
- The bifunctional role of TP53INP2 in transcription and autophagy
- (2020) Yinfeng Xu et al. Autophagy
- Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells
- (2020) Reza Ghasemi et al. LEUKEMIA
- The potential role of RNA N6-methyladenosine in Cancer progression
- (2020) Tianyi Wang et al. Molecular Cancer
- NPM1-mutated acute myeloid leukemia: from bench to bedside
- (2020) Brunangelo Falini et al. BLOOD
- TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells
- (2020) Zhengtao Zhou et al. OncoTargets and Therapy
- TP53INP2 contributes to autophagosome formation by promoting LC3-ATG7 interaction
- (2019) Zhiyuan You et al. Autophagy
- Regulation of death receptor signaling by the autophagy protein TP53INP2
- (2019) Saška Ivanova et al. EMBO JOURNAL
- TP 53 INP 2 mediates autophagic degradation of ubiquitinated proteins through its ubiquitin‐interacting motif
- (2019) Yinfeng Xu et al. FEBS LETTERS
- PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1
- (2019) Giulia Pianigiani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Functions of N6-methyladenosine and its role in cancer
- (2019) Liuer He et al. Molecular Cancer
- Mutant NPM1 Maintains the Leukemic State through HOX Expression
- (2018) Lorenzo Brunetti et al. CANCER CELL
- Biological and clinical consequences of NPM1 mutations in AML
- (2017) E M Heath et al. LEUKEMIA
- NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells
- (2017) Qin Zou et al. Theranostics
- Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia
- (2016) Sujan Piya et al. Autophagy
- Autophagy, a key mechanism of oncogenesis and resistance in leukemia
- (2016) Patrick Auberger et al. BLOOD
- Acute myeloid leukaemia
- (2016) Asim Khwaja et al. Nature Reviews Disease Primers
- TP53INP2/DOR protein chaperones deacetylated nuclear LC3 to the cytoplasm to promote macroautophagy
- (2015) Xu Liu et al. Autophagy
- Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes
- (2014) David Sala et al. JOURNAL OF CLINICAL INVESTIGATION
- Autophagy—a key player in cellular and body metabolism
- (2014) Kook Hwan Kim et al. Nature Reviews Endocrinology
- The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model
- (2013) P. Sportoletti et al. BLOOD
- Correction: DOR/Tp53inp2 and Tp53inp1 Constitute a Metazoan Gene Family Encoding Dual Regulators of Autophagy and Transcription
- (2012) Ana Sancho et al. PLoS One
- The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance
- (2011) Monika Mortensen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TP53INP2 is the new guest at the table of self-eating
- (2009) Jonathan Nowak et al. Autophagy
- The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model
- (2009) K. Cheng et al. BLOOD
- Mammalian autophagy: core molecular machinery and signaling regulation
- (2009) Zhifen Yang et al. CURRENT OPINION IN CELL BIOLOGY
- The nuclear cofactor DOR regulates autophagy in mammalian and Drosophila cells
- (2009) Caroline Mauvezin et al. EMBO REPORTS
- Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications
- (2009) B Falini et al. LEUKEMIA
- Tumor Protein 53-Induced Nuclear Protein 1 Is a Major Mediator of p53 Antioxidant Function
- (2008) C. E. Cano et al. CANCER RESEARCH
- Nucleophosmin Interacts with HEXIM1 and Regulates RNA Polymerase II Transcription
- (2008) Meera Gurumurthy et al. JOURNAL OF MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started